R Zou, W Shi, J Qiu, N Zhou, N Du,
H Zhou… - Cardiovascular …, 2022 - Springer
Background Empagliflozin has been reported to protect endothelial cell function, regardless
of diabetes status. However, the role of empagliflozin in microvascular protection during …